KNE (KNE) News
Follow KNE (KNE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Kane Biotech to host commercial update webcast on September 16
Board Chair Philip Renaud, wound-care surgeon Dr. John C. Lantis and Interim CEO Dr. Robert Huizinga will discuss Kane’s commercial progress, clinical relevance and operational priorities on September 16 webcast.
EQUITY | Sep 09, 2026, 11:11 AM UTC
L
Kane Biotech signs agreement to expand Ontario commercial distribution
Kane Biotech entered into an agreement broadening access to revyve® advanced wound care products through an established Canadian medical supply distributor in Ontario.
EQUITY | Sep 02, 2026, 11:07 AM UTC
M
KNE revenue fell; gross margin improved on revyve shift
KNE reported revenue fell but gross margin improved as focus shifted to revyve wound care products.
EQUITY | Aug 27, 2026, 09:16 PM UTC